Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 18 studies | 32% ± 12% | |
astrocyte | 14 studies | 36% ± 18% | |
microglial cell | 13 studies | 37% ± 13% | |
oligodendrocyte | 11 studies | 34% ± 13% | |
macrophage | 10 studies | 34% ± 15% | |
oligodendrocyte precursor cell | 10 studies | 30% ± 13% | |
fibroblast | 10 studies | 34% ± 10% | |
GABAergic neuron | 9 studies | 38% ± 21% | |
adipocyte | 9 studies | 34% ± 8% | |
glutamatergic neuron | 8 studies | 43% ± 25% | |
ciliated cell | 8 studies | 34% ± 17% | |
B cell | 7 studies | 23% ± 6% | |
endothelial cell of lymphatic vessel | 7 studies | 36% ± 9% | |
interneuron | 6 studies | 39% ± 22% | |
T cell | 6 studies | 24% ± 6% | |
smooth muscle cell | 6 studies | 22% ± 4% | |
neuron | 5 studies | 40% ± 21% | |
epithelial cell | 5 studies | 37% ± 14% | |
type I pneumocyte | 5 studies | 29% ± 7% | |
type II pneumocyte | 5 studies | 28% ± 6% | |
basal cell | 4 studies | 37% ± 19% | |
cardiac muscle cell | 4 studies | 22% ± 2% | |
dendritic cell | 4 studies | 24% ± 3% | |
retinal cone cell | 4 studies | 23% ± 7% | |
retinal rod cell | 4 studies | 30% ± 4% | |
myeloid cell | 4 studies | 34% ± 9% | |
club cell | 4 studies | 34% ± 10% | |
monocyte | 4 studies | 29% ± 8% | |
pericyte | 4 studies | 28% ± 8% | |
GABAergic interneuron | 3 studies | 20% ± 3% | |
plasma cell | 3 studies | 27% ± 8% | |
CD4-positive, alpha-beta T cell | 3 studies | 22% ± 3% | |
mesothelial cell | 3 studies | 33% ± 11% | |
vein endothelial cell | 3 studies | 30% ± 20% | |
Mueller cell | 3 studies | 27% ± 6% | |
T follicular helper cell | 3 studies | 23% ± 6% | |
endothelial cell of vascular tree | 3 studies | 32% ± 13% | |
hepatocyte | 3 studies | 44% ± 22% | |
ependymal cell | 3 studies | 52% ± 12% | |
alveolar macrophage | 3 studies | 29% ± 5% | |
capillary endothelial cell | 3 studies | 19% ± 2% | |
natural killer cell | 3 studies | 21% ± 4% | |
lymphocyte | 3 studies | 35% ± 9% | |
mast cell | 3 studies | 23% ± 6% | |
mucus secreting cell | 3 studies | 29% ± 4% | |
regulatory T cell | 3 studies | 26% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1907.00 | 1445 / 1445 | 100% | 12.77 | 183 / 183 |
prostate | 100% | 2914.89 | 245 / 245 | 100% | 13.54 | 502 / 502 |
stomach | 100% | 1592.87 | 359 / 359 | 100% | 9.19 | 286 / 286 |
lung | 100% | 2333.27 | 578 / 578 | 100% | 10.67 | 1154 / 1155 |
breast | 100% | 2706.03 | 459 / 459 | 100% | 13.51 | 1117 / 1118 |
bladder | 100% | 2396.33 | 21 / 21 | 100% | 10.05 | 503 / 504 |
ovary | 100% | 2526.73 | 180 / 180 | 100% | 9.12 | 429 / 430 |
pancreas | 100% | 1411.45 | 327 / 328 | 100% | 9.52 | 178 / 178 |
thymus | 100% | 3233.11 | 653 / 653 | 100% | 13.42 | 603 / 605 |
skin | 100% | 3104.99 | 1809 / 1809 | 100% | 10.47 | 470 / 472 |
uterus | 100% | 2865.58 | 170 / 170 | 99% | 9.98 | 455 / 459 |
intestine | 100% | 1976.46 | 966 / 966 | 99% | 8.74 | 522 / 527 |
kidney | 100% | 1658.12 | 89 / 89 | 98% | 8.95 | 886 / 901 |
brain | 97% | 859.27 | 2561 / 2642 | 100% | 7.74 | 705 / 705 |
liver | 100% | 1830.77 | 225 / 226 | 97% | 5.30 | 392 / 406 |
adrenal gland | 100% | 1943.86 | 258 / 258 | 96% | 6.15 | 221 / 230 |
adipose | 100% | 2471.71 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2233.16 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 12.79 | 29 / 29 |
spleen | 100% | 2485.55 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 8.47 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.34 | 1 / 1 |
muscle | 100% | 1360.97 | 799 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 1283.55 | 841 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 1390.12 | 895 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 7.32 | 76 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0055088 | Biological process | lipid homeostasis |
GO_0032471 | Biological process | negative regulation of endoplasmic reticulum calcium ion concentration |
GO_0030488 | Biological process | tRNA methylation |
GO_1990845 | Biological process | adaptive thermogenesis |
GO_0002128 | Biological process | tRNA nucleoside ribose methylation |
GO_0098554 | Cellular component | cytoplasmic side of endoplasmic reticulum membrane |
GO_0030234 | Molecular function | enzyme regulator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | THADA |
Protein name | tRNA (32-2'-O)-methyltransferase regulator THADA THADA armadillo repeat containing tRNA (32-2'-O)-methyltransferase regulator THADA (Gene inducing thyroid adenomas protein) (Thyroid adenoma-associated protein) |
Synonyms | GITA KIAA1767 |
Description | FUNCTION: Together with methyltransferase FTSJ1, methylates the 2'-O-ribose of nucleotides at position 32 of the anticodon loop of substrate tRNAs. . FUNCTION: Together with methyltransferase FTSJ1, methylates the 2'-O-ribose of nucleotides at position 32 of the anticodon loop of substrate tRNAs. . |
Accessions | B5MC89 ENST00000398653.5 ENST00000403856.1 ENST00000405975.7 [Q6YHU6-1] B6ZDE5 ENST00000405006.8 [Q6YHU6-1] ENST00000407351.5 ENST00000474159.6 H0Y3V5 ENST00000404790.5 [Q6YHU6-6] ENST00000402796.5 ENST00000402360.6 [Q6YHU6-5] Q6YHU6 H7BYZ4 F5H3M9 ENST00000408045.7 |